Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 2:31 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1297–1320 of 145,369 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Disorders Clear all

Conditions: Leukemia, Systemic Mastocytosis
Interventions: Obatoclax Mesylate; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Autism Spectrum Disorder, Social Skills
Interventions: Animal-assisted intervention, Social skills group; Behavioral
Lead sponsor: Texas Tech University; Other
Eligibility: 11 Years to 17 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Lubbock, Texas

Conditions: Leukemia, Acute Lymphocytic Leukemia
Interventions: Velcade; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Stanford, California

Conditions: Coronary Stenosis, Coronary Artery Disease
Interventions: IoNIR Ridaforolimus-Eluting Coronary Stent System; Device
Lead sponsor: Medinol Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Roslyn, New York

Conditions: Breast Cancer
Interventions: Bevacizumab, Cyclophosphamide, Docetaxel; Drug
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years and older · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2015
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Post Traumatic Stress Disorder, Depression, Violence
Interventions: BSHAPE, Control (general wellness); Behavioral · Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 676 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Severe Asthma
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 60 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Breast Cancer
Interventions: Collection of blood; Other
Lead sponsor: Sanford Health; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1,279 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 2
States / cities: Fargo, North Dakota • Sioux Falls, South Dakota

Conditions: ALS, Amyotrophic Lateral Sclerosis
Interventions: Fosigotifator, Placebo; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 7
States / cities: Irvine, California • Los Angeles, California • San Francisco, California + 4 more

Conditions: Stroke
Interventions: Virtual Reality; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Colon Cancer Liver Metastasis, Colon Cancer, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Liver Metastasis Colon Cancer, Colorectal Cancer
Interventions: Y90 TARE, PET/CT, PET/MRI; Radiation · Diagnostic Test
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Hepatitis B, Chronic
Interventions: Entecavir, Entecavir + Tenofovir; Drug
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 16 Years and older
Enrollment: 669 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 16
States / cities: Los Angeles, California • San Diego, California • San Jose, California + 10 more

Conditions: Influenza, Human
Interventions: 600 mg zanamivir + moxifloxacin placebo, 1200 mg zanamivir + moxifloxacin placebo, zanamivir placebo + moxifloxacin placebo, zanamivir placebo + 400 mg moxifloxacin; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Brain Tumor
Interventions: Magnetic Resonance Imaging, Diffusion Tensor Imaging, Magnetic Resonance Spectroscopic Imaging, Dynamic Contract-Enhanced magnetic resonance imaging, Diffusion-weighted magnetic resonance imaging; Procedure
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Anesthesia, Upper Extremity Injury
Interventions: Retroclavicular Brachial Plexus Block and Catheter Insertion; Procedure
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 100 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Bipolar Disorder
Interventions: Felbamate; Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: Not listed
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2006
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Ischemic Attack, Transient
Interventions: Clopidogrel, placebo; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 4,881 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2018
U.S. locations: 147
States / cities: Chandler, Arizona • Tucson, Arizona • Carmichael, California + 95 more

Conditions: Diabetes
Interventions: Diabetes Survival Skills Training; Behavioral
Lead sponsor: University of Connecticut; Other
Eligibility: 18 Years and older · Male only
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Storrs, Connecticut

Conditions: MPNST, NF1, Sarcoma
Interventions: Selumetinib + ZEN-3694 ± Durvalumab; Combination Product
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 99 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Brain and Central Nervous System Tumors
Interventions: Concurrent temozolomide, Concurrent radiation therapy, 100mg/m2 adjuvant temozolomide days 1 to 5 of 28 day cycle, 75mg/m2 adjuvant temozolomide days 1-21 of 28 day cycle; Drug · Radiation
Lead sponsor: Radiation Therapy Oncology Group; Network
Eligibility: 18 Years to 120 Years
Enrollment: 1,173 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2016
U.S. locations: 341
States / cities: Fairbanks, Alaska • Phoenix, Arizona • Scottsdale, Arizona + 240 more

Conditions: Vaginal Prolapse
Interventions: Not listed
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Atopic Dermatitis
Interventions: IMVAMUNE; Biological
Lead sponsor: Bavarian Nordic; Industry
Eligibility: 18 Years to 40 Years
Enrollment: 632 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2010
U.S. locations: 15
States / cities: Tucson, Arizona • Hot Springs, Arkansas • Garden Grove, California + 11 more

Conditions: Pancreatic Cancer
Interventions: 16S rRNA gene sequencing assay; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 55 Years to 74 Years
Enrollment: 732 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1992 – 2010
U.S. locations: 1
States / cities: New York, New York

Conditions: Cholera (Disorder)
Interventions: VAXCHORA (Cholera Vaccine, Live, Oral), Placebo; Biological · Other
Lead sponsor: Bavarian Nordic; Industry
Eligibility: 2 Years to 17 Years
Enrollment: 550 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 10
States / cities: Atlanta, Georgia • Lenexa, Kansas • Wichita, Kansas + 7 more

Search by objective public record fields.

Obatoclax for Systemic Mastocytosis

Effects of Therapy Dogs on Social Behavior in Group Social Skills Instruction With Children With Autism

Phase II Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia

IonMAN II Trial- Early Feasibility Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System

Primary Systemic Therapy in Operable/Locally Advanced Breast Cancer

Being Safe, Healthy, And Positively Empowered (BSHAPE) Intervention Study

Phenotyping Asthma for Bronchial Thermoplasty

Autoantibodies in Breast Cancer Detection

A Phase 1 Study to Investigate the Safety and Pharmacokinetics of Fosigotifator in Patients With Amyotrophic Lateral Sclerosis

Immersive Virtual Reality in Stroke Pilot Study

Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation

Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B

A Study to Evaluate the Effect of Intravenous Zanamivir on Cardiac Conduction in Healthy Volunteers

Magnetic Resonance Imaging in Evaluating Response to RadiationTherapy in Patients With High Grade Glioma

Clinical Evaluation of the Ultrasound-Guided Retroclavicular Brachial Plexus Block

Clinical Trial of Felbamate for Treatment-Resistant Bipolar Depression

Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial

Diabetes Survival Skills + (DSS+) Training Intervention for Incarcerated Persons Transitioning to the Community (TTC)

Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas

Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

Using a Sheathed Speculum to Visualize and Access the Cervix In Women With Excessive Vaginal Tissue

A Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic Dermatitis

Oral Microbiome and Pancreatic Cancer

VAXCHORA Pediatric Study to Assess Safety and Immunogenicity